Project Details
Short title | A Randomized, Open Label Phase II Study of OSI-211 vs Topotecan in Patients with Relapsed Epothelial Ovarian Cancer |
---|---|
Status | Finished |
Effective start/end date | 1/09/02 → 31/08/05 |
Funding
- OSI PHARMACEUTICALS INC
Short title | A Randomized, Open Label Phase II Study of OSI-211 vs Topotecan in Patients with Relapsed Epothelial Ovarian Cancer |
---|---|
Status | Finished |
Effective start/end date | 1/09/02 → 31/08/05 |